Lump sum or DCA, the latest on Ozempic & a baby Berkshire?
From Equity Mates Investing Podcast
Published 3/31/2024
From Equity Mates Investing Podcast
Published 3/31/2024
Haven't heard much about Ozempic lately? Let us change that and bring you up to speed on some wild developments in the world of weight loss drugs.In this episode we cover:How Novo Nordisk's latest drug has been twice as effective as their existing drugs in early trialsThe growing list of…
